Core Insights - Nanjing Gulou Hospital is enhancing its medical capabilities through systematic planning and continuous investment, boasting 15 national key disciplines and clinical specialties, which significantly improve its overall diagnostic and treatment services [1][2] Group 1: Clinical Achievements - The orthopedic department, led by Professor Jiang Qing, has performed nearly 6,000 surgeries annually, maintaining the highest joint surgery volume in Jiangsu, and has developed a comprehensive prevention model that reduced postoperative thrombosis rates from 74% to 4% [2] - The neurology department, under Professor Xu Yun, is recognized as an international advanced stroke center and has developed an electronic screening platform that covers 52 community health service centers and 231 hospitals, enabling early detection of high-risk patients for Alzheimer's disease [3] - The reproductive medicine center has achieved a success rate of approximately 60% for in vitro fertilization, significantly higher than the national average, and is exploring cutting-edge stem cell technologies to assist previously hopeless infertility cases [3] Group 2: Research and Innovation - The hospital has a strong research foundation with 110 national-level talents and over 500 provincial-level talents, contributing to its high ranking in natural index and numerous prestigious awards [7] - Professor Zhu Dalong's team has developed a novel dual-target glucose-lowering drug, which is the first of its kind globally, addressing the weight gain issue associated with traditional diabetes medications [6] - The hospital has established a concept verification center and a clinical research institute, facilitating the transformation of research outcomes into clinical applications, with 59 successful transformations amounting to 226 million yuan [10] Group 3: Technological Advancements - The hospital is leveraging artificial intelligence in various applications, including a system that generates virtual X-rays from smartphone images for scoliosis screening, which has been patented and is set for community rollout [8] - A new olfactory detection device developed for early identification of cognitive impairments in diabetes patients has reduced screening time to 15 minutes and has already generated 20 million yuan in revenue [9] - The hospital's AI initiatives have improved diagnostic accuracy for pancreatic cancer and significantly reduced report writing time for medical imaging [11] Group 4: Strategic Goals - Nanjing Gulou Hospital aims to establish itself as a leading medical and research center, focusing on high-quality healthcare services and innovative medical solutions, with plans to apply for national medical center status and develop multiple top-tier disciplines [12]